Fred Manby
Co-Founder & CTO of Iambic Therapeutics
Fred Manby is a scientist and entrepreneur focused on integration of AI technologies and high-throughput experimentation in small-molecule drug discovery. He received a DPhil in Chemistry from the University of York, and spent around 20 years as an academic, primarily as a Professor at the University of Bristol in the UK, before leaving to co-found Iambic in 2019.
Title + bullets:
How an AI-driven platform powers drug discovery at Iambic
Innovations in machine learning at Iambic solve major challenges in drug discovery
Machine learning is enabled through (and is enabling for) data generation with laboratory automation
The AI platform at Iambic drives a pipeline of discovery projects across various protein classes and mechanisms of actio



Speakers
















































